Medicalgorithmics

Medicalgorithmics EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicalgorithmics (MDG.WA) as of Nov 22, 2026 is -9.76 M PLN. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -12.90 M PLN — a change of -24.39% (higher).

EBITDA

-9.76 MPLN

YoY

-24.39%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicalgorithmics is 2025 -9.76 M PLN. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicalgorithmics was 2024 -12.90 M PLN. It decreases by -24.39% higher compared to the previous year.

The Medicalgorithmics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
24.72 M PLN
Jan 1, 2019
-146,000.00 PLN
Jan 1, 2020
-37.51 M PLN
Jan 1, 2021
-5.45 M PLN
Jan 1, 2022
21.23 M PLN
Jan 1, 2023
2.80 M PLN
Jan 1, 2024
-12.90 M PLN
Jan 1, 2025
-9.76 M PLN
The Medicalgorithmics EBITDA history
YEAREBITDAYoY
-9.76 MPLN-24.39%
-12.90 MPLN-561.15%
2.80 MPLN-86.82%
21.23 MPLN-489.72%
-5.45 MPLN-85.48%
-37.51 MPLN+25,590.41%
-146,000.00PLN-100.59%
24.72 MPLN-40.88%
41.82 MPLN-10.12%
46.53 MPLN+120.24%
21.13 MPLN+52.08%
13.89 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA develops and manufactures the PocketECG system for remote heart arrhythmia diagnosis and monitoring, used in clinical drug trials for cardiac safety. The company provides IT and biotechnology services, scientific R&D in natural sciences, and works on tele-rehabilitation cardiology devices, hospital task optimization software, and remote ECG description systems. Its products serve healthcare providers, pharmaceutical companies conducting cardiac safety trials, and medical institutions requiring remote cardiac monitoring solutions. The firm operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC, offering diagnostic technology and related services to global healthcare markets. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicalgorithmics is -9.76 M PLN in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medicalgorithmics changed from -12.90 M PLN to -9.76 M PLN, representing a -24.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medicalgorithmics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Medicalgorithmics

All Key Metrics — Medicalgorithmics